Scalable Runtime Architecture for Data-driven, Hybrid HPC and ML Workflow Applications

Hybrid workflows combining traditional HPC and novel ML methodologies are transforming scientific computing. This paper presents the architecture and implementation of a scalable runtime system that extends RADICAL-Pilot with service-based execution to support AI-out-HPC workflows. Our runtime system enables distributed ML capabilities, efficient resource management, and seamless HPC/ML coupling across local and remote platforms. Preliminary experimental results show that our approach manages concurrent execution of ML models across local and remote HPC/cloud resources with minimal architectural overheads. This lays the foundation for prototyping three representative data-driven workflow applications and executing them at scale on leadership-class HPC platforms.

Pandemic Drugs at Pandemic Speed: Accelerating COVID-19 Drug Discovery with Hybrid Machine Learning- and Physics-based Simulations on High Performance Computers

The race to meet the challenges of the global pandemic has served as a reminder that the existing drug discovery process is expensive, inefficient and slow. There is a major bottleneck screening the vast number of potential small molecules to shortlist lead compounds for antiviral drug development. New opportunities to accelerate drug discovery lie at the interface between machine learning methods, in this case developed for linear accelerators, and physics-based methods. The two in silico methods, each have their own advantages and limitations which, interestingly, complement each other. Here, we present an innovative method that combines both approaches to accelerate drug discovery. The scale of the resulting workflow is such that it is dependent on high performance computing. We have demonstrated the applicability of this workflow on four COVID-19 target proteins and our ability to perform the required large-scale calculations to identify lead compounds on a variety of supercomputers.